446 related articles for article (PubMed ID: 20189193)
1. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):305-312.e2. PubMed ID: 20189193
[TBL] [Abstract][Full Text] [Related]
2. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
[TBL] [Abstract][Full Text] [Related]
4. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.
Chung AW; Yang HH; Radomski MW; van Breemen C
Circ Res; 2008 Apr; 102(8):e73-85. PubMed ID: 18388324
[TBL] [Abstract][Full Text] [Related]
5. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
Chung AW; Au Yeung K; Sandor GG; Judge DP; Dietz HC; van Breemen C
Circ Res; 2007 Aug; 101(5):512-22. PubMed ID: 17641224
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome.
Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
Br J Pharmacol; 2009 Nov; 158(6):1503-12. PubMed ID: 19814725
[TBL] [Abstract][Full Text] [Related]
7. miR-29b participates in early aneurysm development in Marfan syndrome.
Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
[TBL] [Abstract][Full Text] [Related]
8. MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome.
Xiong W; Meisinger T; Knispel R; Worth JM; Baxter BT
Circ Res; 2012 Jun; 110(12):e92-e101. PubMed ID: 22550139
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
[TBL] [Abstract][Full Text] [Related]
10. [Naringenin inhibits thoracic aortic aneurysm formation in mice with Marfan syndrome].
Li ZQ; Yu B; Cai ZY; Wang YB; Zhang X; Zhou B; Fang XH; Yu F; Fu Y; Sun JP; Li W; Kong W
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):896-906. PubMed ID: 36241232
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
Chung AW; Au Yeung K; Cortes SF; Sandor GG; Judge DP; Dietz HC; van Breemen C
Br J Pharmacol; 2007 Apr; 150(8):1075-83. PubMed ID: 17339838
[TBL] [Abstract][Full Text] [Related]
12. The role of β-arrestin2-dependent signaling in thoracic aortic aneurysm formation in a murine model of Marfan syndrome.
Wisler JW; Harris EM; Raisch M; Mao L; Kim J; Rockman HA; Lefkowitz RJ
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1516-27. PubMed ID: 26371162
[TBL] [Abstract][Full Text] [Related]
13. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.
Habashi JP; Judge DP; Holm TM; Cohn RD; Loeys BL; Cooper TK; Myers L; Klein EC; Liu G; Calvi C; Podowski M; Neptune ER; Halushka MK; Bedja D; Gabrielson K; Rifkin DB; Carta L; Ramirez F; Huso DL; Dietz HC
Science; 2006 Apr; 312(5770):117-21. PubMed ID: 16601194
[TBL] [Abstract][Full Text] [Related]
14. Regional changes in elastic fiber organization and transforming growth factor β signaling in aortas from a mouse model of marfan syndrome.
Howell DW; Popovic N; Metz RP; Wilson E
Cell Tissue Res; 2014 Dec; 358(3):807-19. PubMed ID: 25238995
[TBL] [Abstract][Full Text] [Related]
15. Redox Dysregulation of Vascular Smooth Muscle Sirtuin-1 in Thoracic Aortic Aneurysm in Marfan Syndrome.
Budbazar E; Sulser Ponce De Leon S; Tsukahara Y; Liu H; Huangfu Y; Wang Y; Seabra PM; Yang X; Goodman JB; Wan X; Chitalia V; Han J; Seta F
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):e339-e357. PubMed ID: 37288573
[TBL] [Abstract][Full Text] [Related]
16. Altered tissue behavior of a non-aneurysmal descending thoracic aorta in the mouse model of Marfan syndrome.
Haskett D; Doyle JJ; Gard C; Chen H; Ball C; Estabrook MA; Encinas AC; Dietz HC; Utzinger U; Vande Geest JP; Azhar M
Cell Tissue Res; 2012 Jan; 347(1):267-77. PubMed ID: 22105919
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?
Matt P; Habashi J; Carrel T; Cameron DE; Van Eyk JE; Dietz HC
J Thorac Cardiovasc Surg; 2008 Feb; 135(2):389-94. PubMed ID: 18242274
[TBL] [Abstract][Full Text] [Related]
18. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
Emrich FC; Okamura H; Dalal AR; Penov K; Merk DR; Raaz U; Hennigs JK; Chin JT; Miller MO; Pedroza AJ; Craig JK; Koyano TK; Blankenberg FG; Connolly AJ; Mohr FW; Alvira CM; Rabinovitch M; Fischbein MP
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):146-54. PubMed ID: 25359856
[TBL] [Abstract][Full Text] [Related]
19. Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress.
Yang HH; van Breemen C; Chung AW
Vascul Pharmacol; 2010; 52(1-2):37-45. PubMed ID: 19879959
[TBL] [Abstract][Full Text] [Related]
20. Androgens Accentuate TGF-β Dependent Erk/Smad Activation During Thoracic Aortic Aneurysm Formation in Marfan Syndrome Male Mice.
Tashima Y; He H; Cui JZ; Pedroza AJ; Nakamura K; Yokoyama N; Iosef C; Burdon G; Koyano T; Yamaguchi A; Fischbein MP
J Am Heart Assoc; 2020 Oct; 9(20):e015773. PubMed ID: 33059492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
